Muscle MRI

OTHER4 trials

Sponsors

Institut de Myologie, France, Assistance Publique Hopitaux De Marseille, University of Pennsylvania, National Taiwan University Hospital

Conditions

Charcot-Marie-Tooth Disease Type 1AMitochondrial DiseasesNeuromuscular DiseasesObesityType 2 Spinal Muscular AtrophyType 3 Spinal Muscular Atrophy

Unknown Phase

Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy

CompletedNCT02391831

Institut de Myologie, FranceType 2 Spinal Muscular Atrophy, Type 3 Spinal Muscular Atrophy

Start: 2015-05-31End: 2018-06-30Updated: 2018-07-19

Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers

Active, not recruitingNCT02596191

Assistance Publique Hopitaux De MarseilleCharcot-Marie-Tooth Disease Type 1A

Start: 2016-06-06End: 2027-12-05Target: 80Updated: 2025-06-27

Muscle OXPHOS and Nutrient Homeostasis

CompletedNCT02920671

University of PennsylvaniaMitochondrial Diseases, Obesity

Start: 2017-02-14End: 2024-08-28Updated: 2024-09-03

The Neuroimage Study of the Neuromuscular Disorders.

RecruitingNCT05048862

National Taiwan University HospitalNeuromuscular Diseases

Start: 2021-08-01End: 2031-08-01Target: 500Updated: 2023-10-31

Related Papers

Insulin Sensitivity and Insulin Secretion in Adults With Friedreich's Ataxia: The Role of Skeletal Muscle

The Journal of Clinical Endocrinology & Metabolism2024-08-072 citations

Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA).

2023-02-0362 citations

187 SUNFISH Part 2: 24-month efficacy of risdiplam compared with external control comparators

Journal of Neurology Neurosurgery & Psychiatry2022-08-121 citations

Natural History of Type 2 and 3 Spinal Muscular Atrophy (SMA): Longitudinal 2-year NatHis-SMA Study (530)

Neurology2020-04-144 citations

MON-LB030 Muscle Mitochondrial Oxidative Phosphorylation Capacity and Whole Body Glucose Metabolism in Friedreich's Ataxia

Journal of the Endocrine Society2019-04-01

Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study

PLoS ONE2018-07-26146 citations